Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. (Q41230771)
Jump to navigation
Jump to search
scientific article published on September 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials. |
scientific article published on September 1996 |
Statements
Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials (English)
R B Devereux
E Agabiti-Rosei
B Dahlöf
R T Hahn
P M Okin
1 September 1996
S95-101; discussion S101-2